Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Glucocorticoids for Acute Radiation-Induced Intestinal Injury
NCT06410443Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of dexamethasone in radiation-induced intestinal injury (RIII) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Recovery and/or improvement of acute radiation-induced intestinal injury at 3 months. Started Aug 2024; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
radiation-induced intestinal injury (RIII)
Beyond the preview
Go deeper on NCT06410443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06410443.